Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia (2021)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-23752-2
PubMed Identifier: 34112805
Publication URI: http://europepmc.org/abstract/MED/34112805
Type: Journal Article/Review
Parent Publication: Nature Communications
Issue: 1
ISSN: 2041-1723